Log in

NASDAQ:SNDXSyndax Pharmaceuticals News Headlines

$15.69
-0.31 (-1.94 %)
(As of 05/26/2020 04:00 PM ET)
Add
Compare
Today's Range
$15.65
Now: $15.69
$17.77
50-Day Range
$8.94
MA: $14.84
$20.98
52-Week Range
$5.35
Now: $15.69
$21.97
Volume1.04 million shs
Average Volume600,511 shs
Market Capitalization$566.33 million
P/E RatioN/A
Dividend YieldN/A
Beta1.93

Headlines

Syndax Pharmaceuticals (NASDAQ SNDX) News Headlines

Source:
DateHeadline
Does Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Have A Particularly Volatile Share Price?Does Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Have A Particularly Volatile Share Price?
finance.yahoo.com - May 25 at 5:02 PM
Syndax Pharmaceuticals (NASDAQ:SNDX) Receives "Buy" Rating from NomuraSyndax Pharmaceuticals (NASDAQ:SNDX) Receives "Buy" Rating from Nomura
www.americanbankingnews.com - May 25 at 10:48 AM
Fiery Biotech Stock Crashes On Late-Stage Failure In Breast CancerFiery Biotech Stock Crashes On Late-Stage Failure In Breast Cancer
finance.yahoo.com - May 22 at 5:45 PM
Syndax Pharmaceuticals (NASDAQ:SNDX) Cut to Neutral at HC WainwrightSyndax Pharmaceuticals (NASDAQ:SNDX) Cut to Neutral at HC Wainwright
www.americanbankingnews.com - May 22 at 1:41 PM
Stock Alert: Synadax Down 18%Stock Alert: Synadax Down 18%
www.nasdaq.com - May 22 at 12:45 PM
Syndax Pharmas entinostat comes up empty again in breast cancer studySyndax Pharma's entinostat comes up empty again in breast cancer study
seekingalpha.com - May 22 at 12:45 PM
Syndax Pharmaceuticals Crashes On Late-Stage Failure In Breast CancerSyndax Pharmaceuticals Crashes On Late-Stage Failure In Breast Cancer
finance.yahoo.com - May 22 at 12:45 PM
Syndax Pharmaceuticals (NASDAQ:SNDX) Lifted to "Buy" at CitigroupSyndax Pharmaceuticals (NASDAQ:SNDX) Lifted to "Buy" at Citigroup
www.americanbankingnews.com - May 22 at 12:16 PM
Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target Cut to $23.00Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target Cut to $23.00
www.americanbankingnews.com - May 22 at 8:17 AM
ECOG-ACRIN Provides Syndax Pharmaceuticals With Results of Phase 3 E2112 Trial of Entinostat Plus Exemestane in Patients with HR+, HER2- Breast CancerECOG-ACRIN Provides Syndax Pharmaceuticals With Results of Phase 3 E2112 Trial of Entinostat Plus Exemestane in Patients with HR+, HER2- Breast Cancer
finance.yahoo.com - May 21 at 7:57 PM
Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target Increased to $22.00 by Analysts at Morgan StanleySyndax Pharmaceuticals (NASDAQ:SNDX) Price Target Increased to $22.00 by Analysts at Morgan Stanley
www.americanbankingnews.com - May 21 at 11:54 AM
Syndax Pharmaceuticals (NASDAQ:SNDX) Downgraded to Neutral at CitigroupSyndax Pharmaceuticals (NASDAQ:SNDX) Downgraded to Neutral at Citigroup
www.americanbankingnews.com - May 18 at 9:53 AM
Syndax Pharmaceuticals Inc (NASDAQ:SNDX) Receives Average Recommendation of "Buy" from BrokeragesSyndax Pharmaceuticals Inc (NASDAQ:SNDX) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - May 18 at 4:36 AM
Syndax Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional SharesSyndax Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
www.prnewswire.com - May 12 at 4:39 PM
Syndax Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional SharesSyndax Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
finance.yahoo.com - May 12 at 4:39 PM
Syndax Pharmaceuticals (NASDAQ:SNDX) PT Raised to $25.00 at HC WainwrightSyndax Pharmaceuticals (NASDAQ:SNDX) PT Raised to $25.00 at HC Wainwright
www.americanbankingnews.com - May 11 at 9:14 AM
Syndax Pharmaceuticals, Inc. (SNDX) CEO Briggs Morrison on Q1 2020 Results - Earnings Call TranscriptSyndax Pharmaceuticals, Inc. (SNDX) CEO Briggs Morrison on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 4:32 PM
Syndax Pharmaceuticals (NASDAQ:SNDX) Posts Quarterly  Earnings Results, Misses Estimates By $0.05 EPSSyndax Pharmaceuticals (NASDAQ:SNDX) Posts Quarterly Earnings Results, Misses Estimates By $0.05 EPS
www.americanbankingnews.com - May 10 at 12:39 PM
Edited Transcript of SNDX earnings conference call or presentation 7-May-20 8:30pm GMTEdited Transcript of SNDX earnings conference call or presentation 7-May-20 8:30pm GMT
finance.yahoo.com - May 8 at 4:38 PM
Syndax Pharmaceuticals (NASDAQ:SNDX) Given New $31.00 Price Target at NomuraSyndax Pharmaceuticals (NASDAQ:SNDX) Given New $31.00 Price Target at Nomura
www.americanbankingnews.com - May 8 at 11:52 AM
Syndax Pharmaceuticals EPS misses by $0.05, revenue in-lineSyndax Pharmaceuticals EPS misses by $0.05, revenue in-line
seekingalpha.com - May 7 at 9:12 PM
Syndax Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Clinical and Business UpdateSyndax Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Clinical and Business Update
finance.yahoo.com - May 7 at 4:10 PM
SYNDAX PHARMACEUTICALS, INC. (NASDAQ:SNDX) Files An 8-K Entry into a Material Definitive AgreementSYNDAX PHARMACEUTICALS, INC. (NASDAQ:SNDX) Files An 8-K Entry into a Material Definitive Agreement
www.marketwatch.com - May 4 at 3:28 PM
Syndax prices stock offering at $18; shares ahead 3% premarketSyndax prices stock offering at $18; shares ahead 3% premarket
seekingalpha.com - May 1 at 10:08 AM
Syndax to Announce First Quarter 2020 Financial Results and Host Conference Call and Webcast on May 7, 2020Syndax to Announce First Quarter 2020 Financial Results and Host Conference Call and Webcast on May 7, 2020
finance.yahoo.com - April 30 at 5:47 PM
Syndax Announces Pricing of Public Offering of Common StockSyndax Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - April 30 at 5:47 PM
Syndax plans stock offering after nearly doubling this weekSyndax plans stock offering after nearly doubling this week
seekingalpha.com - April 29 at 7:09 PM
Syndax Announces Proposed Public Offering of Common StockSyndax Announces Proposed Public Offering of Common Stock
finance.yahoo.com - April 29 at 7:09 PM
Axsomes Alzheimers Positive Results, And Other News: The Good, Bad And Ugly Of BiopharmaAxsome's Alzheimer's Positive Results, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - April 29 at 2:05 PM
The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's KeytrudaThe Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda
finance.yahoo.com - April 29 at 2:05 PM
Syndax +21.6% on leukemia drug dataSyndax +21.6% on leukemia drug data
seekingalpha.com - April 28 at 11:03 PM
Mid-Day Market Update: NASDAQ Turns Negative; Syndax Pharmaceuticals Shares JumpMid-Day Market Update: NASDAQ Turns Negative; Syndax Pharmaceuticals Shares Jump
www.benzinga.com - April 28 at 1:02 PM
Syndax rally lifts Kura Oncology, up 40%Syndax rally lifts Kura Oncology, up 40%
seekingalpha.com - April 28 at 1:02 PM
One Biotech Stock Is Up 57% After Presenting at a Big Cancer Conference. Here’s Why.One Biotech Stock Is Up 57% After Presenting at a Big Cancer Conference. Here’s Why.
www.barrons.com - April 28 at 1:02 PM
Why This Bullishly Ranked Biotech Stock Just Broke Out To A Record HighWhy This Bullishly Ranked Biotech Stock Just Broke Out To A Record High
finance.yahoo.com - April 28 at 1:02 PM
Why Syndax Is Skyrocketing 55% TodayWhy Syndax Is Skyrocketing 55% Today
finance.yahoo.com - April 28 at 1:02 PM
Syndax +21.6% after early leukemia-drug dataSyndax +21.6% after early leukemia-drug data
seekingalpha.com - April 27 at 9:21 PM
Syndax Pharmaceuticals (SNDX) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseSyndax Pharmaceuticals (SNDX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
finance.yahoo.com - April 27 at 4:20 PM
Syndax Pharmaceuticals Announces Preclinical Profile and Initial Phase 1 Data Demonstrating Clinical Activity of Menin Inhibitor SNDX-5613 in Adults with Relapsed/Refractory Acute LeukemiasSyndax Pharmaceuticals Announces Preclinical Profile and Initial Phase 1 Data Demonstrating Clinical Activity of Menin Inhibitor SNDX-5613 in Adults with Relapsed/Refractory Acute Leukemias
finance.yahoo.com - April 27 at 4:20 PM
Syndax Pharmaceuticals Announces Three Presentations at the 2020 American Association for Cancer Research Virtual Annual MeetingSyndax Pharmaceuticals Announces Three Presentations at the 2020 American Association for Cancer Research Virtual Annual Meeting
finance.yahoo.com - April 14 at 9:44 AM
Edited Transcript of SNDX earnings conference call or presentation 3-Mar-20 9:30pm GMTEdited Transcript of SNDX earnings conference call or presentation 3-Mar-20 9:30pm GMT
finance.yahoo.com - April 2 at 3:30 PM
Will 2020 Be An Exciting And Transformative Year For Syndax Pharma (SNDX)?Will 2020 Be An Exciting And Transformative Year For Syndax Pharma (SNDX)?
www.nasdaq.com - March 6 at 8:07 AM
Syndax Pharmaceuticals (SNDX) Presents At Cowen Health Care Conference - SlideshowSyndax Pharmaceuticals (SNDX) Presents At Cowen Health Care Conference - Slideshow
seekingalpha.com - March 5 at 10:45 AM
Will Syndax Pharmaceuticals Continue to Surge Higher?Will Syndax Pharmaceuticals Continue to Surge Higher?
finance.yahoo.com - March 5 at 10:45 AM
Syndax Pharmaceuticals, Inc. (SNDX) CEO Briggs Morrison on Q4 2019 Results - Earnings Call TranscriptSyndax Pharmaceuticals, Inc. (SNDX) CEO Briggs Morrison on Q4 2019 Results - Earnings Call Transcript
seekingalpha.com - March 3 at 11:57 PM
Syndax Pharmaceuticals EPS beats by $0.01, beats on revenueSyndax Pharmaceuticals EPS beats by $0.01, beats on revenue
seekingalpha.com - March 3 at 6:53 PM
Syndax Pharmaceuticals Reports Fourth Quarter 2019 Financial Results and Provides Clinical and Business UpdateSyndax Pharmaceuticals Reports Fourth Quarter 2019 Financial Results and Provides Clinical and Business Update
finance.yahoo.com - March 3 at 6:53 PM
Syndax Pharmaceuticals (SNDX) Reports Q4 LossSyndax Pharmaceuticals (SNDX) Reports Q4 Loss
finance.yahoo.com - March 3 at 6:53 PM
Syndax Pharmaceuticals IncSyndax Pharmaceuticals Inc
www.bloomberg.com - February 21 at 6:08 PM
Syndax Announces Participation at Two Upcoming Investor ConferencesSyndax Announces Participation at Two Upcoming Investor Conferences
finance.yahoo.com - February 18 at 11:23 AM
This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.